Navigation Links
Abbott Announces Positive Nine-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent

Absorbable Stent Continues to Show Promise as Future-Generation Technology

BARCELONA, Spain, May 22, 2007 /PRNewswire-FirstCall/ -- Abbott today announced positive results from ABSORB, the world's first clinical trial evaluating the safety and performance of a fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease. Nine-month results from the first 30 patients in the trial, presented today at the EuroPCR meeting, demonstrated no stent thrombosis and a low (4.0 percent, one patient) rate of Major Adverse Cardiac Events (MACE), such as heart attack or repeat interventional medical treatment. The results confirm the six-month findings from ABSORB, which were announced in March 2007, and show no new adverse events between six and nine months.

"These ABSORB nine-month data reaffirm the positive results we saw with Abbott's bioabsorbable stent system at six months," said ABSORB investigator Dariusz Dudek, M.D., Jagiellonian University in Krakow, Poland. "As we continue the ABSORB trial, we look forward to evaluating an updated version of the stent system designed to deliver additional support to the arterial wall and with the potential to reduce late lumen loss (vessel renarrowing) even further."

Abbott's everolimus eluting bioabsorbable stent is made of polylactic acid, a proven biocompatible material that is commonly used in medical implants such as dissolvable sutures. As with a metallic stent, Abbott's bioabsorbable stent is designed to restore blood flow by propping a clogged vessel open, and provide support until the blood vessel heals. Unlike a metallic stent however, a bioabsorbable stent is designed to be slowly metabolized by the body and completely absorbed over time.

At the EuroPCR meeting, Abbott will unveil an updated, bioabsorbable stent design that will be used in the next cohort of patients enrolled in the ABSORB trial. The new stent features
'"/>




Page: 1 2 3

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
3. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
4. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
5. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
6. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
7. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
8. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
9. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/20/2009)...K, Nov. 20 Reportlinker.com announ... in its catalogue. ,, Global Self Monitoring B... Drive Growth ,, http://www.reportlinker.com...ket-(SMBG )-Increasing-Adoption-to-Drive-Growth.ht..._campaign=prnewswire ,, Description ,, Gl...
(Date:11/20/2009)...K, Nov. 20 Reportlinker.com announ... in its catalogue. ,, Medical Adhesives and Se...portlinker.com/p0164242/Medical-Adhesives-and-Seal...re&utm_medium=pr&utm_campaign=prnewswire ...s gaining preeminence in medical devices and equip...
(Date:11/20/2009)...ES, N.J., Nov. 20 BD (Be...announced the completion of its acquisition of Han...that develops and manufactures molecular diagnosti...09, BD and HandyLab announced an exclusive agreeme...ssays on the HandyLab Jaguar(TM) platform, the fir...
Breaking Medicine Technology:Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Stillbirth Not an Issue for Next Born 51358 1Stillbirth Not an Issue for Next Born 51358 2Researchers consider herd movements to help eradicate bovine TB 51355 1Researchers consider herd movements to help eradicate bovine TB 51355 2Texas Humane Legislation Network Calls for Puppy Mill Crackdown 51352 1Texas Humane Legislation Network Calls for Puppy Mill Crackdown 51352 2
...Ventilator Clinical Trials Also Underw...Biomedical Inc., (http://www.synapsebiomedical.com...he U.S. Food and Drug Administration (FDA) for its...d Injury (SCI) patients who lack voluntary,control... patients and,their caregivers throughout the U.S....
...oma,Society (LLS) and Memgen jointly announced an ...inical trial. The trial will use Memgen,s,ISF35, a...ic lymphocytic,leukemia (CLL)., Based on its alli...nical trial this year for up to 12 patients who ha...therapeutic options. Patients will receive three,i...
Other Medicine Technology:Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 2Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 3Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 4Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 5Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 6The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial 3
(Date:11/21/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNew...nate voted to proceed to Senator Reid,s version of... several objectionable items included in this bill...mandates, is the government funding for elective a...ectionable. Additionally the bill provides subsidi...
(Date:11/21/2009)..., , "This bill provides for an unprec...at is health care about if it is not for preservin...ended, it must be defeated." Charmaine Yoest ,... Americans United for Life Action President and CE...in the Senate by releasing the following statement...
(Date:11/21/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNe...990s to eliminate onchocerciasis (river blindness)...valence of the disease in recent years, as evidenc...requiring mass drug administration in six endemic ...h annual meeting of the American Society of Tropic...
(Date:11/21/2009)..., , LONDON, November 21, 2009 /PRNewswi...t Test Test Test Test Test Test Test Test Test Tes...t Test Test Test Test Test Test Test,Test Test Tes..., More test More test More test More test Mo...re test More test More test More test More test Mo...
(Date:11/21/2009)..., Innovative medical appa...9 conference , San Clemen...eg;, maker of breakthrough medical apparel, today ... are on display at Medica 2009, a leading internat...Dusseldorf, Germany. Medelita inaugurates its men,...
Breaking Medicine News(10 mins):Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3
...ble in French . , A new study led by McGill Univ...irus (HPV) screening test is far more accurate tha...ancer. The first round of the Canadian Cervical Ca...hat the HPV test,s ability to accurately detect pr...
... Health and,disability insurance companies are sy...sults of an investigation of practices by health a... are detailed in this new JustHealth-,funded study... one cause of personal bankruptcy. We pay much mo...
...Accelerate Manufacture of Clinical Trial ...LS, Mich., Oct. 17 Regulatory Affairs,Associates ...FDA approval,for new drugs and medical devices, ha...cture of drugs used in clinical,trials called "NDX...
... following release,was issued today by the Democra...at Susan Orr, a staunch anti-family planning,advoc...tion programs at the,Department of Health and Huma...ublican politics ahead of what,s best for,the Amer...
...er example of the Bush Administration promoting, p... not be entrusted with, the oversight of the fed... millions of Americans, WASHI...ion Affairs (DASPA). DASPA oversees,Title X, the n...
... Kyphon Inc.,(Nasdaq: KYPH ) today announced that...oundation (IOF) and the Foundation for Osteoporosi... about osteoporosis and spinal,fracture risk durin...o raise awareness of ways to maintain healthy bone...
Other Medicine News:Health News:Study: HPV test beats Pap in detecting cervical cancer 2Health News:Study: HPV test beats Pap in detecting cervical cancer 3Health News:Practices in Health & Disability Insurance - The Lives & Wealth They Cost America 2Health News:Regulatory Affairs Associates Gets New Drugs Tested Faster, Wins 2007 Innovation Michigan Award 2Health News:National Abortion Federation Denounces the Appointment of Dr. Orr to Oversee Federal Family Planning Funds 2Health News:Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk 2Health News:Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk 3
Bipolar Bayonet Forceps
Elmed Extra Long Straight Bipolar Forceps
Micro Forceps
Bi-Co-Matic Handswitching Bipolar Micro Forceps with Elmed Fitting, Insulated
Medicine Products: